Clinical Trial

Nonhealing Venous Leg Ulcers Treated With a Standard of Care (SoC) Alone or Standard of Care and Dehydrated Human Placenta Tissue (dHPT) With Crossover

Study acronym: EVOLVE
Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of venous leg ulcers.
Protocol Amendment History 2 changes
critical Enrolling by invitation only 2026-08-07
notable Primary completion moved earlier: 2027-12 -> 2027-08 2026-08-07
Trial Details
NCT Number NCT07230340
Lead Sponsor Cellution Biologics
Conditions Venous Leg Ulcer (VLU)
Enrollment 70 participants
Start Date 2026-02-04
Primary Completion 2027-08 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06